68.48
前日終値:
$67.94
開ける:
$65.255
24時間の取引高:
6.27M
Relative Volume:
0.74
時価総額:
$11.55B
収益:
$803.32M
当期純損益:
$-709.10M
株価収益率:
-8.7791
EPS:
-7.8003
ネットキャッシュフロー:
$-212.68M
1週間 パフォーマンス:
-4.30%
1か月 パフォーマンス:
-23.80%
6か月 パフォーマンス:
+5.71%
1年 パフォーマンス:
+20.93%
Tempus Ai Inc Stock (TEM) Company Profile
TEM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TEM
Tempus Ai Inc
|
68.48 | 12.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
293.36 | 47.81B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
HQY
Healthequity Inc
|
101.77 | 8.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
49.62 | 9.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.32 | 6.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-21 | 開始されました | BTIG Research | Buy |
| 2025-02-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 再開されました | TD Cowen | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-12-09 | 開始されました | Guggenheim | Buy |
| 2024-11-11 | ダウングレード | Stifel | Buy → Hold |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-12 | 開始されました | Piper Sandler | Neutral |
| 2024-07-09 | 開始されました | BofA Securities | Buy |
| 2024-07-09 | 開始されました | JP Morgan | Overweight |
| 2024-07-09 | 開始されました | Longbow | Buy |
| 2024-07-09 | 開始されました | Loop Capital | Buy |
| 2024-07-09 | 開始されました | Morgan Stanley | Overweight |
| 2024-07-09 | 開始されました | Needham | Buy |
| 2024-07-09 | 開始されました | Stifel | Buy |
| 2024-07-09 | 開始されました | TD Cowen | Buy |
| 2024-07-09 | 開始されました | William Blair | Outperform |
すべてを表示
Tempus Ai Inc (TEM) 最新ニュース
Will Tempus AI Inc. price bounce be sustainable2025 Top Decliners & Free Risk Controlled Daily Trade Plans - newser.com
Best Artificial Intelligence Stocks To Watch NowNovember 16th - MarketBeat
How analysts rate Tempus AI Inc. stock todayWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com
Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat - MSN
How to build a custom watchlist for Tempus AI Inc.Portfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Real time alert setup for Tempus AI Inc. performanceShort Setup & Real-Time Chart Breakout Alerts - newser.com
Can Tempus AI Inc. stock rebound after recent weakness2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
How Investors Are Reacting To Tempus AI (TEM) Earnings Surge and New Lymphoma Research Partnership - Yahoo Finance
Tempus AI: Opportunity To Build Position (NASDAQ:TEM) - Seeking Alpha
Is Tempus AI Inc. trending in predictive chart modelsJuly 2025 Review & Expert Approved Momentum Ideas - newser.com
Can Tempus AI Inc. stock resist sector downturnsJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Tempus AI, Inc. $TEM Shares Purchased by Calamos Advisors LLC - MarketBeat
What makes Tempus AI Inc. (F3M) stock appealing to growth investorsWatch List & Consistent Growth Equity Picks - newser.com
Baillie Gifford Reduces Stake in Tempus AI Inc: A Strategic Portfolio Adjustment - GuruFocus
Artificial Intelligence Stocks Worth WatchingNovember 14th - MarketBeat
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Yahoo Finance
Will Tempus AI Inc. stock benefit from green energy trendsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Full technical analysis of Tempus AI Inc. stockQuarterly Market Summary & Free High Return Stock Watch Alerts - newser.com
What is the fair value of Tempus AI Inc. stock now2025 Pullback Review & AI Forecasted Entry and Exit Points - Fundação Cultural do Pará
TEM Continues to Strengthen Its Genomics Leadership With New Products - sharewise.com
Tempus AI Partners With IFLI Over New Research Study on Follicular Lymphoma - MarketScreener
Tempus and IFLI partner on follicular lymphoma research study - Investing.com India
Tempus and IFLI partner on follicular lymphoma research study By Investing.com - Investing.com South Africa
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research - Business Wire
Insider Sell: Jennifer Doudna Sells Shares of Tempus AI Inc (TEM) - GuruFocus
Can Tempus AI Inc. (F3M) stock stage a strong rebound this quarterInsider Buying & Technical Entry and Exit Tips - newser.com
Artificial Intelligence Stocks To Watch NowNovember 11th - MarketBeat
Promising Artificial Intelligence Stocks Worth WatchingNovember 13th - MarketBeat
Transcript : Tempus AI, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-13-2025 10 - MarketScreener
Tempus AI: Great Buying Opportunity On Recent Weakness (NASDAQ:TEM) - Seeking Alpha
Tempus: Diagnostics Substance, AI Flash (NASDAQ:TEM) - Seeking Alpha
Artificial Intelligence Stocks To Follow TodayNovember 10th - MarketBeat
10 Best Digital Health Stocks to Buy Now - Insider Monkey
Tempus AI’s Earnings Call Highlights Strong Growth Amid Challenges - MSN
Tempus AI: A Good Bet For The Future Of Health Care (NASDAQ:TEM) - Seeking Alpha
Promising Artificial Intelligence Stocks To ResearchNovember 9th - MarketBeat
Piper Sandler Maintains Tempus AI (TEM) Neutral Recommendation - Nasdaq
Piper Sandler Cuts Tempus AI (NASDAQ:TEM) Price Target to $80.00 - MarketBeat
Tempus AI (TEM): Morgan Stanley Raises Price Target Following To - GuruFocus
Piper Sandler Lowers Tempus AI (TEM) Price Target but Maintains Neutral Rating | TEM Stock News - GuruFocus
Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release? - sharewise.com
Tempus AI price target raised to $80 from $68 at Morgan Stanley - TipRanks
Tempus Ai Inc (TEM) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):